308 related articles for article (PubMed ID: 16625093)
41. Epstein-Barr virus-negative post-transplant lymphoproliferative disorders: a distinct entity?
Nelson BP; Nalesnik MA; Bahler DW; Locker J; Fung JJ; Swerdlow SH
Am J Surg Pathol; 2000 Mar; 24(3):375-85. PubMed ID: 10716151
[TBL] [Abstract][Full Text] [Related]
42. Lymphoma resembling Hodgkin disease after posttransplant lymphoproliferative disorder in a liver transplant recipient.
Nalesnik MA; Randhawa P; Demetris AJ; Casavilla A; Fung JJ; Locker J
Cancer; 1993 Nov; 72(9):2568-73. PubMed ID: 8402478
[TBL] [Abstract][Full Text] [Related]
43. Clinicopathologic characteristics of post-transplant lymphoproliferative disorders.
Nalesnik MA
Recent Results Cancer Res; 2002; 159():9-18. PubMed ID: 11785849
[TBL] [Abstract][Full Text] [Related]
44. Differentiation of EBV-induced post-transplant Hodgkin lymphoma from Hodgkin-like post-transplant lymphoproliferative disease.
Rohr JC; Wagner HJ; Lauten M; Wacker HH; Jüttner E; Hanke C; Pohl M; Niemeyer CM
Pediatr Transplant; 2008 Jun; 12(4):426-31. PubMed ID: 18466428
[TBL] [Abstract][Full Text] [Related]
45. Successful treatment of a classic Hodgkin lymphoma-type post-transplant lymphoproliferative disorder with tailored chemotherapy and Epstein-Barr virus-specific cytotoxic T lymphocytes in a pediatric heart transplant recipient.
Basso S; Zecca M; Calafiore L; Rubert L; Fiocchi R; Paulli M; Quartuccio G; Guido I; Sebastiani R; Croci GA; Beschi C; Nardiello I; Ginevri F; Cugno C; Comoli P
Pediatr Transplant; 2013 Nov; 17(7):E168-73. PubMed ID: 23992468
[TBL] [Abstract][Full Text] [Related]
46. Patterns of Epstein-Barr virus latent and replicative gene expression in Epstein-Barr virus B cell lymphoproliferative disorders after organ transplantation.
Rea D; Fourcade C; Leblond V; Rowe M; Joab I; Edelman L; Bitker MO; Gandjbakhch I; Suberbielle C; Farcet JP
Transplantation; 1994 Aug; 58(3):317-24. PubMed ID: 8053055
[TBL] [Abstract][Full Text] [Related]
47. Classical Hodgkin lymphoma type post-transplant lymphoproliferative disorder in a kidney transplant recipient: a diagnostic pitfall.
Mohri T; Ikura Y; Hirakoso A; Okamoto M; Hishizawa M; Takaori-Kondo A; Kato S; Nakamura S; Yoshimura K; Okabe H; Iwai Y
Int J Hematol; 2018 Aug; 108(2):218-227. PubMed ID: 29380181
[TBL] [Abstract][Full Text] [Related]
48. CD20 expression predicts survival in paediatric post-transplant lymphoproliferative disease (PTLD) following solid organ transplantation.
Orjuela MA; Alobeid B; Liu X; Siebert AL; Kott ER; Addonizio LJ; Morris E; Garvin JH; Lobritto SJ; Cairo MS
Br J Haematol; 2011 Mar; 152(6):733-42. PubMed ID: 21275950
[TBL] [Abstract][Full Text] [Related]
49. Posttransplant Hodgkin lymphoma preceded by polymorphic posttransplant lymphoproliferative disorder: report of a pediatric case and review of the literature.
Gheorghe G; Albano EA; Porter CC; McGavran L; Wei Q; Meltesen L; Danielson SM; Liang X
J Pediatr Hematol Oncol; 2007 Feb; 29(2):112-6. PubMed ID: 17279008
[TBL] [Abstract][Full Text] [Related]
50. EBV-associated B- and T-cell posttransplant lymphoproliferative disorders following primary EBV infection in a kidney transplant recipient.
Yin CC; Medeiros LJ; Abruzzo LV; Jones D; Farhood AI; Thomazy VA
Am J Clin Pathol; 2005 Feb; 123(2):222-8. PubMed ID: 15842046
[TBL] [Abstract][Full Text] [Related]
51. The Impact of EBV Status on Characteristics and Outcomes of Posttransplantation Lymphoproliferative Disorder.
Luskin MR; Heil DS; Tan KS; Choi S; Stadtmauer EA; Schuster SJ; Porter DL; Vonderheide RH; Bagg A; Heitjan DF; Tsai DE; Reshef R
Am J Transplant; 2015 Oct; 15(10):2665-73. PubMed ID: 25988622
[TBL] [Abstract][Full Text] [Related]
52. How I treat posttransplant lymphoproliferative disorder.
Amengual JE; Pro B
Blood; 2023 Oct; 142(17):1426-1437. PubMed ID: 37540819
[TBL] [Abstract][Full Text] [Related]
53. The role of quantitative Epstein-Barr virus polymerase chain reaction and preemptive immunosuppression reduction in pediatric liver transplantation: a preliminary experience.
Kogan-Liberman D; Burroughs M; Emre S; Moscona A; Shneider BL
J Pediatr Gastroenterol Nutr; 2001 Oct; 33(4):445-9. PubMed ID: 11698761
[TBL] [Abstract][Full Text] [Related]
54. Post-transplant lymphoproliferative diseases in Asian solid organ transplant recipients: late onset and favorable response to treatment.
Chan TS; Hwang YY; Gill H; Au WY; Leung AY; Tse E; Chim CS; Loong F; Kwong YL
Clin Transplant; 2012; 26(5):679-83. PubMed ID: 22324300
[TBL] [Abstract][Full Text] [Related]
55. Initial spontaneous remission of posttransplantation Epstein Barr virus-related B-cell lymphoproliferative disorder of the skin in a renal transplant recipient: case report and review of the literature on cutaneous B-cell posttransplantation lymphoproliferative disease.
Blokx WA; Andriessen MP; van Hamersvelt HW; van Krieken JH
Am J Dermatopathol; 2002 Oct; 24(5):414-22. PubMed ID: 12357204
[TBL] [Abstract][Full Text] [Related]
56. Epstein-Barr virus-negative lymphoproliferate disorders in long-term survivors after heart, kidney, and liver transplant.
Dotti G; Fiocchi R; Motta T; Gamba A; Gotti E; Gridelli B; Borleri G; Manzoni C; Viero P; Remuzzi G; Barbui T; Rambaldi A
Transplantation; 2000 Mar; 69(5):827-33. PubMed ID: 10755535
[TBL] [Abstract][Full Text] [Related]
57. Peripheral T-cell lymphoma with Reed-Sternberg-like cells of B-cell phenotype and genotype associated with Epstein-Barr virus infection.
Quintanilla-Martinez L; Fend F; Moguel LR; Spilove L; Beaty MW; Kingma DW; Raffeld M; Jaffe ES
Am J Surg Pathol; 1999 Oct; 23(10):1233-40. PubMed ID: 10524524
[TBL] [Abstract][Full Text] [Related]
58. Primary CNS EBV-positive post-transplant lymphoproliferative disorder with polymorphic and classic Hodgkin lymphoma features: A case report and literature review.
Mulligan M; Flavin R; Beausang A
Clin Neuropathol; 2023; 42(4):161-167. PubMed ID: 37073959
[TBL] [Abstract][Full Text] [Related]
59. Distinctive Clinicopathologic Features of Monomorphic B-cell Post-transplant Lymphoproliferative Disorders in Children.
Zhang Y; Mariani R; Gong M; Kirschmann D; Caparelli E; Wallace N; Turner R; Lu X; Gao J; Yap KL; Gong S
Pediatr Dev Pathol; 2021; 24(4):318-326. PubMed ID: 33872109
[TBL] [Abstract][Full Text] [Related]
60. Association between HLA-A1 and -A2 types and Epstein-Barr virus status of post-transplant lymphoproliferative disorder.
Kinch A; Sundström C; Tufveson G; Glimelius I
Leuk Lymphoma; 2016 Oct; 57(10):2351-8. PubMed ID: 27104753
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]